Global Drug Discovery Outsourcing Market, By Drug Type (Small Molecules, Large Molecules), Workflow (Target Identification and Screening, Target Validation and Functional Informatics, Lead Identification and Candidate Optimization, Preclinical Development, Others), Therapeutic Area (Respiratory System, Pain and Anaesthesia, Oncology, Ophthalmology, Haematology, Cardiovascular, Endocrine, Gastrointestinal, Immunomodulation, Anti-Infective, Central Nervous System, Dermatology, Genitourinary System), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights of Drug Discovery Outsourcing
Drug discovery outsourcing market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 5.65 billion by 2028 and will grow at a CAGR of 8.75% in the above mentioned forecast period.
Drug discovery outsourcing is the procedure that is used to find new medicines or drugs in different fields such as pharmacology, pharmaceuticals and biotechnology. Also the drug discovery outsourcing is the beginning phase of the drug development process.
The rising trend of partnerships in drug discovery research across the world is amongst the important factors intensifying the growth and demand of drug discovery outsourcing market. In addition, the increasing prevalence rate of metabolic, genetic and other chronic diseases and technology advancement in drug discovery are also contributing to the growth in the global market over the forecast period of 2021 to 2028. Also the rising usage of AI in drug discovery as well rapid shift toward patent expiration, biologics, and unprecedented downsizing of internal discovery of big pharmaceuticals are also enhancing the growth of the market. Rising incidences of antibiotic resistance as well as drug resistance will also make sure high industry growth over the forecast period.
The strong presence of leading pharmaceutical and biotechnology companies along with increasing focus by pharmaceutical companies on improving the efficacy of drug development and rapid development of new drugs are offering significant growth opportunities for the market in the forecast period of 2021 to 2028.
However, the high cost as well as the high risk of drug failure will curb the growth of the drug discovery outsourcing market, whereas the lack of skilled professionals have the potential to challenge the growth of the drug discovery outsourcing market.
This drug discovery outsourcing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on drug discovery outsourcing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Drug Discovery Outsourcing Market Scope and Market Size
Drug discovery outsourcing market is segmented on the basis of drug type, workflow and therapeutic area. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on drug type, the drug discovery outsourcing market is segmented into small molecules and large molecules.
- On the basis of workflow, the drug discovery outsourcing market is segmented into target identification and screening, target validation and functional informatics, lead identification and candidate optimization, preclinical development and others.
- The therapeutic area segment of drug discovery outsourcing market is segmented into respiratory system, pain and anaesthesia, oncology, ophthalmology, haematology, cardiovascular, endocrine, gastrointestinal, immunomodulation, anti-infective, central nervous system, dermatology and genitourinary system.
Drug Discovery Outsourcing Market Country Level Analysis
Drug discovery outsourcing market is analyzed and market size insights and trends are provided by country, drug type, workflow and therapeutic area as referenced above.
The countries covered in the drug discovery outsourcing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region leads the drug discovery outsourcing market owing to the high adoption of technological advancements as well as the strong presence of well-established research infrastructure and increasing investments in drug discovery R&D within the region. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the increasing trend of outsourcing manufacturing and R&D activities to countries such as China and India within this particular region.
The country section of the drug discovery outsourcing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Drug discovery outsourcing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for drug discovery outsourcing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the drug discovery outsourcing market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Drug Discovery Outsourcing Market Share Analysis
Drug discovery outsourcing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to drug discovery outsourcing market.
The major players covered in the drug discovery outsourcing market report are Charles River Laboratories, Albany Molecular Research Inc., Thermo Fisher Scientific, Jubilant Biosys, Eurofins Scientific, GVK Biosciences Private Limited, Aurigene Pharmaceutical Services Ltd., Selvita, Dalton Pharma Services, QIAGEN, Syngene International Limited, SRI INTERNATIONAL, Merck KGaA, Covance Inc., Nanosyn, Bioduro, Sygnature Discovery, Laboratory Corporation of America Holdings, Domainnex and GenScript, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-
